Literature DB >> 2162877

Treating hypertension in the older person: an evaluation of the association of blood pressure level and its reduction with cognitive performance.

A S Bird1, R A Blizard, A H Mann.   

Abstract

No adverse effect upon cognitive function has been detected during the first 9 months of treatment by a thiazide diuretic (Moduretic; Merck Sharp & Dohme, Hoddesdon, UK) or a beta-blocking agent (atenolol) of moderately elevated blood pressure in a cohort of 2630 men and women aged between 65 and 74 years. Furthermore, no association was discovered between levels of systolic or diastolic blood pressure at outset and responses to standard tests of cognitive function. This study was carried out in general practices as part of the current Medical Research Council Treatment Trial of Mild Hypertension in the Elderly.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2162877     DOI: 10.1097/00004872-199002000-00008

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  14 in total

1.  Assessment of changes in psychomotor performance of elderly subjects.

Authors:  L Kalra; S H Jackson; C G Swift
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

2.  The effects of two centrally-acting anti-hypertensive drugs on the quality of life.

Authors:  A E Fletcher; D G Beevers; C T Dollery; R Wilkinson; C J Bulpitt
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  Psychomotor performance and antihypertensive treatment.

Authors:  L Kalra; C G Swift; S H Jackson
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

4.  Factors associated with low cognitive performance in general practice.

Authors:  M J Dealberto; B Sauron; C Derouesné; P Boyer; D Mayeux; F Piette; F Kohler; S Lubin; A Alpérovitch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

Review 5.  Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications.

Authors:  Guido Grassi; Michele Bombelli; Gianmaria Brambilla; Fosca Quarti Trevano; Raffaella Dell'oro; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

Review 6.  Calcium antagonists in the elderly. A risk-benefit analysis.

Authors:  J B Schwartz
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

Review 7.  Choosing the optimum therapy for older hypertensive patients.

Authors:  W H Birkenhäger
Journal:  Drugs Aging       Date:  1991-01       Impact factor: 3.923

Review 8.  The effect of antihypertensive treatment on the quality of later years.

Authors:  M A James; J F Potter
Journal:  Drugs Aging       Date:  1993 Jan-Feb       Impact factor: 3.923

Review 9.  Report of the Canadian Hypertension Society Consensus Conference: 4. Hypertension in the elderly.

Authors:  R A Reeves; J G Fodor; C I Gryfe; C Patterson; J D Spence
Journal:  CMAJ       Date:  1993-09-15       Impact factor: 8.262

10.  Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults.

Authors:  M J Prince; A S Bird; R A Blizard; A H Mann
Journal:  BMJ       Date:  1996-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.